A Double-blind, Placebo-controlled, Randomized Study of the Safety and Efficacy of NH001 in Improving the Functional Outcome of Patients in a Vegetative State or Minimally Conscious State Following a Severe Traumatic Brain Injury
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2017
Price : $35 *
At a glance
- Drugs Apomorphine (Primary)
- Indications Persistent vegetative state
- Focus Therapeutic Use
- Sponsors NeuroHealing Pharmaceuticals
- 29 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
- 29 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.
- 19 May 2014 New trial record